Abstract: Provided herein are vaccines including coronavirus antigens and E6020, as well as methods of mitigation of coronavirus infection by administering those vaccines.

Abstract: Methods, systems, and computer-readable media are disclosed herein for generating a user-interactive partogram in a graphical user interface using cloud deployment and multi-application integration.

Abstract: An method to detect anomalies in financial transactions which may be used to assess a risk of fraud is provided. The method comprises providing a computer-implemented approval log which stores a primary account number and one or more transaction attributes from a plurality of approved financial transactions associated with the primary account number. A computer-implemented approval anomaly detector is also provided to assess the plurality of approval events. These anomalies are then made available to one or more parties associated with the payment interchange network.

Abstract: An method to detect anomalies in financial transactions which may be used to assess a risk of fraud is provided. The method comprises providing a computer-implemented approval log which stores a primary account number and one or more transaction attributes from a plurality of approved financial transactions associated with the primary account number. A computer-implemented approval anomaly detector is also provided to assess the plurality of approval events. These anomalies are then made available to one or more parties associated with the payment interchange network.

Abstract: Embodiments of the disclosure relate to selectively substituted quinolone compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Abstract: Systems and methods for managing payment network transactions to a group account associated with a group are disclosed. One example system includes a memory including a data structure. The data structure includes transaction data representing multiple payment network transactions to the group account. Each of the multiple transactions is identified, in the transaction data, to one of multiple members of the group. The system includes a processor coupled to the memory and configured to cause a member interface to be displayed at a computing device associated with a first member of the group. The member interface includes a first indicator associated with the first member and representative of transactions identified to the first member, and the member interface includes a second indicator associated with a second member of the group and representative of one or more transactions identified to the second member.

Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Abstract: The present invention provides methods for preparing TLR-4 receptor agonist E6020: and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates.

Abstract: The present invention provides methods for preparing TLR-4 receptor agonist E6020: and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates.

Abstract: A floor mat system comprising a base mat having at least one recess for accommodating at least one machine washable or disposable shoe cleaning pad. A shoe scuff member may be located in the center of at least one recess within the base mat or may be located on at least one of the shoe cleaning pads. The shoe scuff member may have a shape suitable to allow a user to manually clean pair of shoes. Dirt containment flaps may be located on the perimeter edges of at least one of the shoe cleaning pads. The dirt containment flaps encourage containment of the dirt within at least one shoe cleaning pad simplifying routine cleaning of at least one recess of the base mat. The base mat may also contain channels and/or liquid solution reservoirs.

Abstract: The present invention provides methods for preparing TLR-4 receptor agonist E6020: and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates.

Abstract: The present invention provides methods for preparing TLR-4 receptor agonist E6020: and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates.

Abstract: The present invention provides methods for preparing TLR-4 receptor agonist E6020: and stereoisomers thereof, which compounds are useful as an immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases. Also provided are synthetic intermediates.

Abstract: Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.